Evolution of cancer treatment and evolving challenges.

about

Evolution of cancer treatment and evolving challenges.

Item

http://www.wikidata.org/entity/Q49628203

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Evolution of cancer treatment and evolving challenges.

@en

Evolution of cancer treatment and evolving challenges.

@nl

type

Item

label

Evolution of cancer treatment and evolving challenges.

@en

Evolution of cancer treatment and evolving challenges.

@nl

prefLabel

Evolution of cancer treatment and evolving challenges.

@en

Evolution of cancer treatment and evolving challenges.

@nl

P1476

Evolution of cancer treatment and evolving challenges.

@en

P2093

Lynne Nakashima

http://www.w3.org/2001/XMLSchema#string

P2860

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review

Cost-effectiveness research in cancer therapy: a systematic review of literature trends, methods and the influence of funding

Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center.

Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund.

Efficacy, safety, tolerability and price of newly approved drugs in solid tumors.

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Economic burden of cancer across the European Union: a population-based cost analysis.

Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.

High cancer drug prices in the United States: reasons and proposed solutions.

P304

26-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1177/0840470417722568

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264971

http://www.w3.org/2001/XMLSchema#string